Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDB1- and CUL4-associated factor 12-like protein 2 (DCAF12L2) is a member of the WD repeat protein family, characterized by repeating units facilitating protein-protein interactions and assembly of multiprotein complexes. DCAF12L2 is thought to function as an adapter or substrate recognition component in cullin-RING E3 ubiquitin ligase complexes, specifically the CUL4-DDB1 complex, though its direct biochemical activities and substrates remain uncharacterized. The gene is an intronless retrocopy, is expressed in humans, and is conserved across several mammals. While WD repeat proteins in general are implicated in diverse processes such as cell cycle regulation, signal transduction, and apoptosis, the precise physiological and pathological roles of DCAF12L2 remain unclear, and it is not presently considered a validated therapeutic target[4][6][7].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDB1- and CUL4-associated factor 12-like protein 2 (DCAF12L2).